Extendicare Inc.
EXETF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 12.4% | 6.8% | 4.7% | – |
| Cost of Goods Sold | $0 | $1 | $1 | $1 |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 100% | 12.8% | 6.3% | 9.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $0 | $1 | $0 |
| SG&A Expenses | $1 | $0 | $1 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $0 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 7.6% | 8.6% | 1.7% | 5.4% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $0 | -$0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 5.1% | 2.6% | 5.7% | 1% |
| EPS | 0.92 | 0.4 | -0.053 | 0.13 |
| % Growth | 130% | 860.5% | -140.5% | – |
| EPS Diluted | 0.86 | 0.4 | -0.053 | 0.11 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 10.6% | 7.6% | 4% | 6.4% |